Post by Xaira Therapeutics

We’re proud to see our Head of Biomedical AI Bo Wang take the stage at NVIDIA's #GTC2026, the premier global AI conference. Building on the momentum behind our recent unveiling of X-Cell, Xaira Therapeutics’ first virtual cell model, Bo joined an esteemed panel to discuss how AI-enabled technology is poised to push the boundaries of the biological scaling laws that have limited the processes behind drug discovery — until now. As Bo said: it’s not just about generating more data, but the right kinds of data. Well done to all of the panelists: Ron Alfa, MD, PhD, Emma Lundberg, Daniel Burkhardt and Philipp Lorenz.